Shawn Assad - 01 Jul 2022 Form 4 Insider Report for GeneDx Holdings Corp. (WGS)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
31 May 2023, 16:17:37 UTC
Prior SEC filing
12 May 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Shawn Assad

Key filing fact

Shawn Assad filed Form 4 for GeneDx Holdings Corp. (WGS) on 31 May 2023.

Key facts

  • This page summarizes Shawn Assad's Form 4 filing for GeneDx Holdings Corp. (WGS).
  • 6 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 31 May 2023, 16:17.

Change

  • Previous filing in this sequence was filed on 12 May 2022.
  • Current net transaction value: -$8,844.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

WGS transaction

Class A Common Stock

Options Exercise

Transaction value
Shares
+5,139
Change %
+16%
Price
Shares after
37,246
Date
01 Jul 2022
Ownership
Direct
Footnotes
F1
WGS transaction

Class A Common Stock

Sale

Transaction value
$1,974
Shares
-1,497
Change %
-4%
Price
$1.32
Shares after
35,749
Date
05 Jul 2022
Ownership
Direct
Footnotes
F2, F3
WGS transaction

Class A Common Stock

Options Exercise

Transaction value
Shares
+10,457
Change %
+29%
Price
Shares after
46,206
Date
10 Aug 2022
Ownership
Direct
Footnotes
F1
WGS transaction

Class A Common Stock

Sale

Transaction value
$6,870
Shares
-3,166
Change %
-6.9%
Price
$2.17
Shares after
43,040
Date
12 Aug 2022
Ownership
Direct
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

WGS transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
$0
Shares
-5,139
Change %
-6.2%
Price
$0.000000
Shares after
77,097
Date
01 Jul 2022
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
5,139
Exercise price
Footnotes
F1, F4
WGS transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
$0
Shares
-10,457
Change %
-8.3%
Price
$0.000000
Shares after
115,037
Date
10 Aug 2022
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
10,457
Exercise price
Footnotes
F1, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.

Footnote F2

The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Footnote F3

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.215 to $1.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F4

6.25% of the total shares underlying the restricted stock units vest in quarterly installments beginning on July 1, 2022 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.

Footnote F5

1/16th of the total shares vested beginning on October 25, 2021, and thereafter vests as to 1/16th of the total shares underlying the award in quarterly installments until fully vested on May 10, 2025, subject to the Reporting Person's continued service to the Issuer on each vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .